NL-OMON36016已完成不适用
Test-retest of the newly developed P-gp PET tracer [11C]laniquidar in healthy volunteers - Test-retest of the P-gp PET tracer [11C]laniquidar in healthy volunteers
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age between 18-65 years
- •- Good physical health evaluated by medical history, physical (including neurological) examination and screening laboratory tests
- •- Weight >50 kg
- •- RDC diagnosis never mentally ill
- •- Written informed consent of each subject
排除标准
- •- Any clinical significant abnormality of any clinical laboratory test - Any subject who has received any investigational medication within 30 days prior to the start of this study, or who is scheduled to receive an investigational drug - Major psychiatric or neurological disorder - History of alcohol and/or drug abuse (DSM-IV criteria) - History of coagulation problems - Any sign of cardiovascular disease - Current use of any medication, other than contraceptive medication - Breast feeding - Pregnancy - Unable to understand or read the Dutch language
研究者
相似试验
已完成
不适用
Test-retest of the newly developed P-gp PET tracer [11C]phenytoin in healthy volunteersgeen (nu nog in gezonde mensen)NL-OMON37882Vrije Universiteit Medisch Centrum12
招募中
不适用
Test-retest of the P-gp PET tracer [11C]laniquidar in healthy volunteers.healthy volunteersNL-OMON27121VU University Medical Center12
尚未招募
不适用
Onderzoek ter evaluatie van de test -retest variatie van [11C]fenytoine in gezonde vrijwilligers.- pharmacoresistant epilepsy- Blood Brain Barrier (BBB)- upregulation of multidrug efflux transporters (e.g. P-gp)- brain pharmacokineticsNL-OMON24061Prof. A.A. Lammertsma, PhDHead of the Department of Nuclear Medicine & PET researchVU University Medical CentreDe Boelelaan 11171007 MB AmsterdamT +31204444214F +31204443090E-mail: aa.lammertsma@vumc.nl12
已完成
不适用
Validation of novel PET tracer [11C]-GMOM: Assessment of dosimetry, biodistribution, and specific binding in healthy volunteersonderzoek heeft in de toekomst betrekking op bovenstaande aandoeningen, maar wordt uitgevoerd bij gezonde controlesNMDA receptor function (not a specific disease)1002930510039628NL-OMON39348Vrije Universiteit Medisch Centrum14
已完成
不适用
Validation of the novel PET tracer [18F]PK209 in healthy volunteers: Dosimetry, test-retest, and specific binding to the NMDA receptoronderzoek heeft in de toekomst betrekking op bovenstaande aandoeningen, maar wordt uitgevoerd bij gezonde controlesthere is no disease1002930510039628NL-OMON40871Vrije Universiteit Medisch Centrum14